Lee M. Greenberger
Leukemia and Lymphoma Society(US)
Publications by Year
Research Areas
Drug Transport and Resistance Mechanisms, HER2/EGFR in Cancer Research, Cancer therapeutics and mechanisms, SARS-CoV-2 and COVID-19 Research, Microtubule and mitosis dynamics
Most-Cited Works
- Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein.(2000)
- → Atypical Multidrug Resistance: Breast Cancer Resistance Protein Messenger RNA Expression in Mitoxantrone-Selected Cell Lines(1999)348 cited
- Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C.(1998)
- → Progesterone Interacts with P-Glycoprotein in Multidrug-resistant Cells and in the Endometrium of Gravid Uterus(1989)289 cited
- → 6-Substituted-4-(3-bromophenylamino)quinazolines as Putative Irreversible Inhibitors of the Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor (HER-2) Tyrosine Kinases with Enhanced Antitumor Activity(2001)272 cited
- → Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies(2021)267 cited
- → Synthesis and Structure−Activity Relationships of 6,7-Disubstituted 4-Anilinoquinoline-3-carbonitriles. The Design of an Orally Active, Irreversible Inhibitor of the Tyrosine Kinase Activity of the Epidermal Growth Factor Receptor (EGFR) and the Human Epidermal Growth Factor Receptor-2 (HER-2)